4.5 Article

Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase

Related references

Note: Only part of the references are listed.
Review Immunology

IL-21-Producing Th Cells in Immunity and Autoimmunity

Sue M. Liu et al.

JOURNAL OF IMMUNOLOGY (2013)

Article Neurosciences

T cell-activation in neuromyelitis optica lesions plays a role in their formation

Maria Pohl et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)

Article Clinical Neurology

Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis

Aimin Wu et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)

Article Endocrinology & Metabolism

Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation

Stefan M. Gold et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Multidisciplinary Sciences

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica

Norio Chihara et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Clinical Neurology

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

Akiyuki Uzawa et al.

MULTIPLE SCLEROSIS JOURNAL (2010)

Review Biochemistry & Molecular Biology

Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease

Giovanni Monteleone et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2009)

Article Immunology

IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells

Wendy A. Goodman et al.

JOURNAL OF IMMUNOLOGY (2009)

Review Rheumatology

Heterogeneity of human effector CD4+ T cells

Francesco Annunziato et al.

ARTHRITIS RESEARCH & THERAPY (2009)

Review Clinical Neurology

Neuromyelitis optica: a distinct demyelinating disease of the central nervous system

A. A. Argyriou et al.

ACTA NEUROLOGICA SCANDINAVICA (2008)

Article Multidisciplinary Sciences

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells

Thomas Korn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Clinical Neurology

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica

S. Watanabe et al.

MULTIPLE SCLEROSIS JOURNAL (2007)

Review Clinical Neurology

The spectrum of neuromyelitis optica

Dean M. Wingerchuk et al.

LANCET NEUROLOGY (2007)

Article Clinical Neurology

Revised diagnostic criteria for neuromyelitis optica

D. M. Wingerchuk et al.

NEUROLOGY (2006)

Review Biochemistry & Molecular Biology

NF-kappa B activation pathways induced by T cell costimulation

ML Schmitz et al.

FASEB JOURNAL (2003)

Article Clinical Neurology

Optic neuromyelitis syndrome in Brazilian patients

RM Papais-Alvarenga et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)